83 related articles for article (PubMed ID: 11717917)
1. Sensitization of acnu killing effects on HeLa S3 cells by MGMT antisense RNA transfection.
Ji S; You Y; Wu Y; Chen J; Yang J; Zhang Y
Chin Med Sci J; 1998 Mar; 13(1):14-9. PubMed ID: 11717917
[TBL] [Abstract][Full Text] [Related]
2. Modulation of O6-methylguanine-DNA methyltransferase-mediated 1-(4-amino-2-methyl-5-Pyrimidinyl)- methyl-3-(2-Chloroethyl)-3-nitrosourea resistance by antisense RNA.
Ji SP; Zhang YP
Cancer Detect Prev; 1999; 23(5):422-7. PubMed ID: 10468895
[TBL] [Abstract][Full Text] [Related]
3. Efficient protection of cells from the genotoxicity of nitrosoureas by the retrovirus-mediated transfer of human O6-methylguanine-DNA methyltransferase using bicistronic vectors with human multidrug resistance gene 1.
Suzuki M; Sugimoto Y; Tsuruo T
Mutat Res; 1998 Jun; 401(1-2):133-41. PubMed ID: 9639692
[TBL] [Abstract][Full Text] [Related]
4. Application of antisense ribonucleic acid complementary to O6-methylguanine-deoxyribonucleic acid methyltransferase messenger ribonucleic acid for therapy of malignant gliomas.
Nagane M; Asai A; Shibui S; Nomura K; Kuchino Y
Neurosurgery; 1997 Aug; 41(2):434-40; discussion 440-1. PubMed ID: 9257312
[TBL] [Abstract][Full Text] [Related]
5. Retroviral coexpression of two different types of drug resistance genes to protect normal cells from combination chemotherapy.
Suzuki M; Sugimoto Y; Tsukahara S; Okochi E; Gottesman MM; Tsuruo T
Clin Cancer Res; 1997 Jun; 3(6):947-54. PubMed ID: 9815770
[TBL] [Abstract][Full Text] [Related]
6. [Study on potentiation of nitrosourea-cytotoxicity by DNA repair enzyme inhibitors in human brain tumor cells].
Fukuchi M; Mineura K; Kowada M; Terashima I; Kohda K
No To Shinkei; 1997 Jun; 49(6):521-8. PubMed ID: 9198092
[TBL] [Abstract][Full Text] [Related]
7. Modulation of O6-methylguanine-DNA methyltransferase-mediated 1-(4-amino-2-methyl-5-pyrimidinyl) methyl-3-(2-chloroethyl)-3-nitrosourea resistance by O6-benzylguanine in vitro and in vivo.
Chen JM; Zhang YP; Sui JL; Moschel RC; Ikenaga M
Anticancer Res; 1993; 13(3):801-5. PubMed ID: 8317915
[TBL] [Abstract][Full Text] [Related]
8. [Study on MGMT assay and tumor individual predictable chemotherapy].
Zhang YP
Ai Zheng; 2004 Jun; 23(6):724-34. PubMed ID: 15191682
[TBL] [Abstract][Full Text] [Related]
9. Protective effect of O6-methylguanine-DNA methyltransferase (MGMT) on the cytotoxic and recombinogenic activity of different antineoplastic drugs.
Preuss I; Thust R; Kaina B
Int J Cancer; 1996 Feb; 65(4):506-12. PubMed ID: 8621235
[TBL] [Abstract][Full Text] [Related]
10. Protection of hematopoietic cells from O(6)-alkylation damage by O(6)-methylguanine DNA methyltransferase gene transfer: studies with different O(6)-alkylating agents and retroviral backbones.
Jansen M; Bardenheuer W; Sorg UR; Seeber S; Flasshove M; Moritz T
Eur J Haematol; 2001 Jul; 67(1):2-13. PubMed ID: 11553261
[TBL] [Abstract][Full Text] [Related]
11. The effect of o6-methylguanine-DNA methyltransferase (MGMT) and mismatch repair gene (hMLH1) status on the sensitivity to alkylating agent 1-(4-amino-2-methyl-5-pyrimidinyl)methyl-3-(2-chloroethyl)-3-nitrosourea(ACNU) in gallbladder carcinoma cells.
Sato K; Kitajima Y; Koga Y; Miyazaki K
Anticancer Res; 2005; 25(6B):4021-8. PubMed ID: 16309194
[TBL] [Abstract][Full Text] [Related]
12. Transfer and expression of human O6-methylguanine-DNA methyltransferase cDNA confers resistance of Mer- HeLa MR cells to 1-(4-amino-2-methyl-5-pyrimidinyl)methyl-3-(2-chloroethyl)-3-nitrosoure a.
Yang J; Chen JM; Zhang YP
Carcinogenesis; 1995 Sep; 16(9):2271-4. PubMed ID: 7554090
[TBL] [Abstract][Full Text] [Related]
13. O(6)-methylguanine DNA-methyltransferase (MGMT) overexpression in melanoma cells induces resistance to nitrosoureas and temozolomide but sensitizes to mitomycin C.
Passagne I; Evrard A; Depeille P; Cuq P; Cupissol D; Vian L
Toxicol Appl Pharmacol; 2006 Mar; 211(2):97-105. PubMed ID: 16039682
[TBL] [Abstract][Full Text] [Related]
14. Expression of O6-methylguanine-DNA methyltransferase and chloroethylnitrosourea resistance of human brain tumors.
Nagane M; Asai A; Shibui S; Nomura K; Matsutani M; Kuchino Y
Jpn J Clin Oncol; 1992 Jun; 22(3):143-9. PubMed ID: 1518162
[TBL] [Abstract][Full Text] [Related]
15. Induction of the DNA repair gene O6-methylguanine-DNA methyltransferase by dexamethasone in glioblastomas.
Ueda S; Mineta T; Nakahara Y; Okamoto H; Shiraishi T; Tabuchi K
J Neurosurg; 2004 Oct; 101(4):659-63. PubMed ID: 15481722
[TBL] [Abstract][Full Text] [Related]
16. Targeting of O6-methylguanine-DNA methyltransferase (MGMT) activity by antimessenger oligonucleotide sensitizes CHO/Mex+ transfected cells to mitozolomide.
Citti L; Boldrini L; Preuss I; Kaina B; Mariani L; Rainaldi G
Carcinogenesis; 1996 Jan; 17(1):25-9. PubMed ID: 8565132
[TBL] [Abstract][Full Text] [Related]
17. Cisplatin represses transcriptional activity from the minimal promoter of the O6-methylguanine methyltransferase gene and increases sensitivity of human gallbladder cancer cells to 1-(4-amino-2-methyl-5-pyrimidinyl) methyl-3-2-chloroethyl)-3-nitrosourea.
Sato K; Kitajima Y; Nakagawachi T; Soejima H; Miyoshi A; Koga Y; Miyazaki K
Oncol Rep; 2005 May; 13(5):899-906. PubMed ID: 15809756
[TBL] [Abstract][Full Text] [Related]
18. O(6)-methylguanine-DNA methyltransferase (MGMT) as a determinant of resistance to camptothecin derivatives.
Okamoto R; Takano H; Okamura T; Park JS; Tanimoto K; Sekikawa T; Yamamoto W; Sparreboom A; Verweij J; Nishiyama M
Jpn J Cancer Res; 2002 Jan; 93(1):93-102. PubMed ID: 11802813
[TBL] [Abstract][Full Text] [Related]
19. Modulation of 1,3-bis-(2-chloroethyl)-1-nitrosourea resistance in human tumor cells using hammerhead ribozymes designed to degrade O6-methylguanine DNA methyltransferase mRNA.
Zhang Q; Ohannesian DW; Kreklau EL; Erickson LC
J Pharmacol Exp Ther; 2001 Jul; 298(1):141-7. PubMed ID: 11408535
[TBL] [Abstract][Full Text] [Related]
20. Differential inactivation of O6-methylguanine-DNA methyltransferase activity by O6-arylmethylguanines.
Mineura K; Fukuchi M; Kowada M; Terashima I; Kohda K
Int J Cancer; 1995 Sep; 63(1):148-51. PubMed ID: 7558444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]